Fosamprenavir Calcium Tablet, Coated
Product Images NDC 63304-583

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fosamprenavir Calcium (NDC 63304-583). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image1 (Fosamgraph)

A pharmacokinetic concentration-time graph showing plasma amprenavir concentrations (mcg/mL) over 24 hours for different dosing regimens of LEXIVA (fosamprenavir calcium) with ritonavir, including once and twice daily doses. The plot includes error bars and compares four treatment groups.*

FDA Label Image

Structure (Fosamstr)

Chemical structure of Fosamprenavir Calcium, showing its molecular framework including aromatic rings, sulfonamide group, phosphate moiety, and calcium ion association.*

FDA Label Image

Spl-fosamprenavir-bottle-label (Spl Fosamprenavir Bottle Label)

Label for Fosamprenavir Calcium Tablets 700 mg, oral coated tablets, Rx only, containing 60 tablets. Manufactured by Sun Pharmaceutical Industries, Inc., with a prominent alert box advising consultation about medicines that should not be taken with Fosamprenavir Calcium Tablets. The label includes storage instructions and a space for serialization on the right side.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.